These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16224582)

  • 21. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
    Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.
    Leboeuf J; Basiez M; Massingham R
    Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophysiologic effects of 3-(p-chlorophenyl)-(2-imadazolin-2-yl-methyl)-1,2,3,4-tetrahydro-1-benzepine hydrochloride (SU-13197), a new antiarrhythmic agent.
    Watanabe Y; Dreifus LS
    J Pharmacol Exp Ther; 1968 Jan; 159(1):146-52. PubMed ID: 5643942
    [No Abstract]   [Full Text] [Related]  

  • 24. Basic cardiac electrophysiology and mechanisms of antiarrhythmic agents.
    Perry RS; Illsley SS
    Am J Hosp Pharm; 1986 Apr; 43(4):957-74. PubMed ID: 2871752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptro stimulation and blockade. Part C.
    Wit AL; Hoffman BF; Rosen MR
    Am Heart J; 1975 Dec; 90(6):795-803. PubMed ID: 903
    [No Abstract]   [Full Text] [Related]  

  • 26. Novel antiarrhythmic compounds with combined class IB and class III mode of action.
    Mátyus P; Varga I; Rettegi T; Simay A; Kállay N; Károlyházy L; Kocsis A; Varró A; Pénzes I; Papp JG
    Curr Med Chem; 2004 Jan; 11(1):61-9. PubMed ID: 14754426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro electrophysiological mechanisms for antiarrhythmic efficacy of resveratrol, a red wine antioxidant.
    Chen WP; Su MJ; Hung LM
    Eur J Pharmacol; 2007 Jan; 554(2-3):196-204. PubMed ID: 17107672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of anti-arrhythmia agents of the heart conduction system].
    Kodama I; Anno T
    Nihon Rinsho; 1985 Nov; 43(11):2397-403. PubMed ID: 4087425
    [No Abstract]   [Full Text] [Related]  

  • 29. Electrophysiological actions of lidocaine on canine ventricular muscle and Purkinje fibers.
    Davis LD; Temte JV
    Circ Res; 1969 May; 24(5):639-55. PubMed ID: 5770253
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes.
    Nakaya H; Tohse N; Takeda Y; Kanno M
    Br J Pharmacol; 1993 May; 109(1):157-63. PubMed ID: 7684298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graded responses in isolated kitten atria due to blockade of conduction by cetyltrimethyl-ammonium bromide (CTAB).
    Kadowitz PJ; Hollands M; Dresel PE
    J Pharmacol Exp Ther; 1970 Sep; 174(3):509-16. PubMed ID: 5456182
    [No Abstract]   [Full Text] [Related]  

  • 32. Electrophysiological studies of 6-(N,N-diethylamino)-Hexyl-3,4,5,-Trimethoxybenzoate on ventricular muscle and conduction system.
    Posner P; Chiou CY
    Pharmacology; 1976; 14(2):97-103. PubMed ID: 959320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of action of antiarrhythmic drugs.
    Rosen MR; Hoffman BF
    Circ Res; 1973 Jan; 32(1):1-8. PubMed ID: 4567446
    [No Abstract]   [Full Text] [Related]  

  • 34. Some fundamental actions of antiarrhythmic drugs on the excitability and the contractility of singel myocardial fibers.
    Tritthart H; Fleckenstein B; Fleckenstein A
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(2):212-9. PubMed ID: 4254279
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of aprindine and lidocaine on transmembrane potentials and radioactive K efflux in different cardiac tissues.
    Carmeliet E; Verdonck F
    Acta Cardiol; 1974; Suppl 18():73-90. PubMed ID: 4547403
    [No Abstract]   [Full Text] [Related]  

  • 36. Electrophysiologic effects of bepridil in the anesthetized dog studied by endocardiac electrodes.
    Sassine A; Masse C; Fajuri A; Hirsch JL; Labrid C; Puech P
    Am J Cardiol; 1984 Jun; 53(11):1707-11. PubMed ID: 6610347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiology and pharmacology of cardiac arrhythmias. V. Cardiac antiarrhythmic effects of lidocaine.
    Rosen MR; Hoffman BF; Wit AL
    Am Heart J; 1975 Apr; 89(4):526-36. PubMed ID: 1090140
    [No Abstract]   [Full Text] [Related]  

  • 38. Electrophysiological studies of indecainide hydrochloride, a new antiarrhythmic agent, in canine cardiac tissues.
    Steinberg MI; Wiest SA
    J Cardiovasc Pharmacol; 1984; 6(4):614-21. PubMed ID: 6206315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophysiological effects of OPC-88117, a new antiarrhythmic agent on papillary muscles and single ventricular myocytes isolated from guinea-pig hearts.
    Toyama J; Kodama I; Honjo H; Kamiya K
    Br J Pharmacol; 1989 Sep; 98(1):177-85. PubMed ID: 2553186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiological effects of carocainide (770207) on canine ventricular muscle and Purkinje fibers.
    Pourrias B; Santamaria R
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):85-95. PubMed ID: 6316863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.